The potential antidepressant and antidiabetic effects of galanin system

Pharmacology Biochemistry and Behavior

Volumn 120, Issue , 2014, Pages 82-87

  Fang, Penghua ^a,b   Min, Wen ^b   Sun, Yong ^b   Guo, Lili ^a   Shi, Mingyi ^a   Bo, Ping ^a   Zhang, Zhenwen ^a  

^a YANGZHOU UNIVERSITY   (China)

^b NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Depression; Galanin; Type 2 diabetes mellitus

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; GALANIN; GALANIN RECEPTOR 2; GALANIN RECEPTOR 2 AGONIST; UNCLASSIFIED DRUG;

ANTIDEPRESSANT ACTIVITY; ANTIDIABETIC ACTIVITY; DEPRESSION; DISEASE ASSOCIATION; ELECTRIC POTENTIAL; HUMAN; INSULIN RESISTANCE; MOLECULAR INTERACTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; COMPLICATION; DRUG EFFECTS; PHYSIOLOGY; PSYCHOLOGY;

ANTIDEPRESSIVE AGENTS; DEPRESSION; DIABETES MELLITUS, TYPE 2; GALANIN; HUMANS; HYPOGLYCEMIC AGENTS;

EID: 84896134535     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2014.02.018     Document Type: Review

References (95)

1. H. Abrahamian, P. Hofmann, R. Prager, and H. Toplak Diabetes mellitus and co-morbid depression: treatment with milnacipran results in significant improvement of both diseases (results from the Austrian MDDM study group) Neuropsychiatr Dis Treat 5 2009 261 266
2. H. Abrahamian, P. Hofmann, J. Kinzl, and H. Toplak Diabetes mellitus and comorbid depression: improvement of both diseases with milnacipran. A replication study (results of the Austrian Major Depression Diabetes Mellitus study group) Neuropsychiatr Dis Treat 8 2012 355 360
3. F. Agasse, S. Xapelli, V. Coronas, S.H. Christiansen, A.I. Rosa, and L. Sardá-Arroyo et al. Galanin promotes neuronal differentiation in murine subventricular zone cell cultures Stem Cells Dev 22 2013 1693 1708
4. B. Ahrén, G. Pacini, D. Wynick, N. Wierup, and F. Sundler Loss-of-function mutation of the galanin gene is associated with perturbed islet function in mice Endocrinology 145 2004 3190 3196 (Pubitemid 38829990)
5. M.C. Audet, and H. Anisman Interplay between pro-inflammatory cytokines and growth factors in depressive illnesses Front Cell Neurosci 7 2013 68
6. K.R. Bailey, M.N. Pavlova, A.D. Rohde, J.G. Hohmann, and J.N. Crawley Galanin receptor subtype 2 (GalR2) null mutant mice display an anxiogenic-like phenotype specific to the elevated plus-maze Pharmacol Biochem Behav 86 2007 8 20
7. G. Bandyopadhyay, M.L. Standaert, L. Galloway, J. Moscat, and R.V. Farese Evidence for involvement of protein kinase C (PKC)-ζ and noninvolvement of diacylglycerol-sensitive PKCs in insulin-stimulated glucose transport in L6 myotubes Endocrinology 138 1997 4721 4731 (Pubitemid 27460908)
8. A.M. Barr, J.W. Kinney, M.N. Hill, X. Lu, S. Biros, and J. Rebek Jr. et al. A novel, systemically active, selective galanin receptor type-3 ligand exhibits antidepressant-like activity in preclinical tests Neurosci Lett 405 2006 111 115
9. J. Bassett, A. Adelman, R. Gabbay, and R.M. Aňel-Tiangco Relationship between depression and treatment satisfaction among patients with type 2 diabetes J Diabetes Metab 3 2012 [pii: 1000210]
10. D.O. Borroto-Escuela, M. Narvaez, D. Marcellino, C. Parrado, J.A. Narvaez, and A.O. Tarakanov et al. Galanin receptor-1 modulates 5-hydroxtryptamine-1A signaling via heterodimerization Biochem Biophys Res Commun 393 2010 767 772
11. L. Bu, Z. Liu, J. Zou, X. Gao, Y. Bao, and S. Qu Blocking central galanin receptors attenuates insulin sensitivity in myocytes of diabetic trained rats J Neurosci Res 91 2013 971 977
12. L. Bu, Q. Yao, Z. Liu, W. Tang, J. Zou, and S. Qu Combined galanin with insulin improves insulin sensitivity of diabetic rat muscles J Endocrinol 2014 10.1530/JOE-13-0444
13. S.H. Christiansen Regulation of the galanin system in the brainstem and hypothalamus by electroconvulsive stimulation in mice Neuropeptides 45 2011 337 341
14. S.H. Christiansen, M.V. Olesen, G. Wörtwein, and D.P. Woldbye Fluoxetine reverts chronic restraint stress-induced depression-like behaviour and increases neuropeptide Y and galanin expression in mice Behav Brain Res 216 2011 585 591
15. S. Davidson, M. Lear, L. Shanley, B. Hing, A. Baizan-Edge, and A. Herwig et al. Differential activity by polymorphic variants of a remote enhancer that supports galanin expression in the hypothalamus and amygdala: implications for obesity, depression and alcoholism Neuropsychopharmacology 36 2011 2211 2221
16. A. Engum The role of depression and anxiety in onset of diabetes in a large population-based study J Psychosom Res 62 2007 31 38 (Pubitemid 44937341)
17. P. Fang, M. Yu, M. Shi, Z. Zhang, Y. Sui, and L. Guo et al. Galanin peptide family as a modulating target for contribution to metabolic syndrome Gen Comp Endocrinol 179 2012 115 120
18. P. Fang, M. Yu, L. Guo, P. Bo, Z. Zhang, and M. Shi Galanin and its receptors: a novel strategy for appetite control and obesity therapy Peptides 36 2012 331 339
19. P. Fang, P. Bo, M. Shi, M. Yu, and Z. Zhang Circulating galanin levels are increased in patients with gestational diabetes mellitus Clin Biochem 46 2013 831 833
20. P. Fang, M. Shi, M. Yu, L. Guo, P. Bo, and Z. Zhang Endogenous peptides as risk markers to assess the development of insulin resistance Peptides 51 2014 9 14
21. G. Feixas, A. Bados, E. García-Grau, A. Montesano, G. Dada, and V. Compañ et al. Efficacy of a dilemma-focused intervention for unipolar depression: study protocol for a multicenter randomized controlled trial Trials 14 2013 144
22. P.C. Fontoura, V.L. Pinto, C. Matsuura, C. Resende Ade, G.F. de Bem, and M.R. Ferraz et al. Defective nitric oxide-cyclic guanosine monophosphate signaling in patients with bipolar disorder: a potential role for platelet dysfunction Psychosom Med 74 2012 873 877
23. K. Fuxe, G. von Euler, L.F. Agnati, and S.O. Ogren Galanin selectively modulates 5-hydroxytryptamine 1A receptors in the rat ventral limbic cortex Neurosci Lett 85 1988 163 167 (Pubitemid 18053459)
24. K. Fuxe, D.O. Borroto-Escuela, W. Romero-Fernandez, A.O. Tarakanov, F. Calvo, and P. Garriga et al. On the existence and function of galanin receptor heteromers in the central nervous system Front Endocrinol (Lausanne) 3 2012 127
25. S.H. Golden, M. Lazo, M. Carnethon, A.G. Bertoni, P.J. Schreiner, and A.V. Diez Roux et al. Examining a bidirectional association between depressive symptoms and diabetes JAMA 299 2008 2751 2759 (Pubitemid 351846850)
26. P.J. Goodnick Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy Ann Clin Psychiatry 13 2001 31 41 (Pubitemid 32660581)
27. L. Guariguata By the numbers: new estimates from the IDF Diabetes Atlas Update for 2012 Diabetes Res Clin Pract 98 2012 524 525
28. L. Guo, M. Shi, L. Zhang, G. Li, L. Zhang, and H. Shao et al. Galanin antagonist increases insulin resistance by reducing glucose transporter 4 effect in adipocytes of rats Gen Comp Endocrinol 173 2011 159 163
29. B. He, M. Shi, L. Zhang, G. Li, L. Zhang, and H. Shao et al. Beneficial effect of galanin on insulin sensitivity in muscle of type 2 diabetic rats Physiol Behav 103 2011 284 289
30. A. Holmes, and M.R. Picciotto Galanin: a novel therapeutic target for depression, anxiety disorders and drug addiction? CNS Neurol Disord Drug Targets 5 2006 225 232 (Pubitemid 43796622)
31. M.N. Igwe, R. Uwakwe, C.A. Ahanotu, G.M. Onyeama, M.O. Bakare, and A.C. Ndukuba Factors associated with depression and suicide among patients with diabetes mellitus and essential hypertension in a Nigerian teaching hospital Afr Health Sci 13 2013 68 77
32. L. Jiang, M. Shi, L. Guo, B. He, G. Li, and L. Zhang et al. Effect of M35, a neuropeptide galanin antagonist on glucose uptake translated by glucose transporter 4 in trained rat skeletal muscle Neurosci Lett 467 2009 178 181
33. G. Kaur, G.H. Tee, S. Ariaratnam, A.S. Krishnapillai, and K. China Depression, anxiety and stress symptoms among diabetics in Malaysia: a cross sectional study in an urban primary care setting BMC Fam Pract 14 2013 69
34. M.J. Knol, J.W. Twisk, A.T. Beekman, R.J. Heine, F.J. Snoek, and F. Pouwer Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis Diabetologia 49 2006 837 845
35. V. Kormos, and B. Gaszner Role of neuropeptides in anxiety, stress, and depression: from animals to humans Neuropeptides 47 2013 401 419
36. T. Kozicz Axon terminals containing tyrosine hydroxylase- and dopamine-beta-hydroxylase immunoreactivity form synapses with galanin immunoreactive neurons in the lateral division of the bed nucleus of the stria terminalis in the rat Brain Res 914 2001 23 33 (Pubitemid 32905428)
37. E. Kuteeva, T. Wardi, T. Hökfelt, and S.O. Ogren Galanin enhances and a galanin antagonist attenuates depression-like behaviour in the rat Eur Neuropsychopharmacol 17 2007 64 69 (Pubitemid 44751405)
38. E. Kuteeva, T. Wardi, L. Lundström, U. Sollenberg, U. Langel, and T. Hökfelt et al. Differential role of galanin receptors in the regulation of depression-like behavior and monoamine/stress-related genes at the cell body level Neuropsychopharmacology 33 2008 2573 2585
39. E. Kuteeva, T. Hökfelt, T. Wardi, and S.O. Ogren Galanin, galanin receptor subtypes and depression-like behaviour EXS 102 2010 163 181
40. R. Lang, A.L. Gundlach, and B. Kofler The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease Pharmacol Ther 115 2007 177 207 (Pubitemid 47042915)
41. T.W. Le Maître, S. Xia, E. Le Maitre, X.P. Dun, J. Lu, and E. Theodorsson et al. Galanin receptor 2 overexpressing mice display an antidepressive-like phenotype: possible involvement of the subiculum Neuroscience 190 2011 270 288
42. I.N. Legakis The role of galanin in metabolic disorders leading to type 2 diabetes mellitus Drug News Perspect 18 2005 173 177 (Pubitemid 40704838)
43. I. Legakis, T. Mantzouridis, and T. Mountokalakis Positive correlation of galanin with glucose in type 2 diabetes Diabetes Care 28 2005 759 760 (Pubitemid 40315353)
44. I.N. Legalkis, T. Mantzouridis, and T. Mountokalakis Positive correlation of galanin with glucose in healthy volunteers during an oral glucose tolerance test Horm Metab Res 39 2007 53 55 (Pubitemid 46535157)
45. G.M. Leggio, S. Salomone, C. Bucolo, C. Platania, V. Micale, and F. Caraci et al. Dopamine D3 receptor as a new pharmacological target for the treatment of depression Eur J Pharmacol 719 2013 25 33
46. T. Leone, E. Coast, S. Narayanan, and Aikins A. de Graft Diabetes and depression comorbidity and socio-economic status in low and middle income countries (LMICs): a mapping of the evidence Global Health 8 2012 39
47. Y. Liang, S. Sheng, P. Fang, Y. Ma, J. Li, and Q. Shi et al. Exercise-induced galanin release facilitated GLUT4 translocation in adipocytes of type 2 diabetic rats Pharmacol Biochem Behav 100 2012 554 559
48. X. Lu, A.M. Barr, J.W. Kinney, P. Sanna, B. Conti, and M.M. Behrens et al. A role for galanin in antidepressant actions with a focus on the dorsal raphe nucleus Proc Natl Acad Sci U S A 102 2005 874 879 (Pubitemid 40282758)
49. X. Lu, B. Ross, M. Sanchez-Alavez, E.P. Zorrilla, and T. Bartfai Phenotypic analysis of GalR2 knockout mice in anxiety- and depression-related behavioral tests Neuropeptides 42 2008 387 397
50. L. Lundström, A. Elmquist, T. Bartfai, and U. Langel Galanin and its receptors in neurological disorders Neuromolecular Med 7 2005 157 180 (Pubitemid 41278195)
51. S. Luo, J. Luo, and A.H. Cincotta Chronic ventromedial hypothalamic infusion of norepinephrine and serotonin promotes insulin resistance and glucose intolerance Neuroendocrinology 70 1999 460 465 (Pubitemid 30009035)
52. P.J. Lustman, K.E. Freedland, L.S. Griffith, and R.E. Clouse Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial Diabetes Care 23 2000 618 623 (Pubitemid 30321540)
53. Z. Lysy, D. Da Costa, and K. Dasgupta The association of physical activity and depression in type 2 diabetes Diabet Med 25 2008 1133 1141
54. J. Masmoudi, R. Damak, H. Zouari, U. Ouali, A. Mechri, and N. Zouari et al. Prevalence and impact of anxiety and depression on type 2 diabetes in Tunisian patients over sixty years old Depress Res Treat 2013 2013 341782
55. B. Mezuk, W.W. Eaton, S. Albrecht, and S.H. Golden Depression and type 2 diabetes over the lifespan: a meta-analysis Diabetes Care 31 2008 2383 2390
56. P.S. Murray, J.L. Groves, B.J. Pettett, S.L. Britton, L.G. Koch, and R.K. Dishman et al. Locus coeruleus galanin expression is enhanced after exercise in rats selectively bred for high capacity for aerobic activity Peptides 31 2010 2264 2268
57. A. Nouwen, K. Winkley, J. Twisk, C.E. Lloyd, M. Peyrot, and K. Ismail et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis Diabetologia 53 2010 2480 2486
58. S.A. Oak, C. Tran, G. Pan, M. Thamotharan, and S.U. Devaskar Perturbed skeletal muscle insulin signaling in the adult female intrauterine growth-restricted rat Am J Physiol Endocrinol Metab 290 2006 E1321 E1330
59. P.J. O'Connor, A.L. Crain, W.A. Rush, A.M. Hanson, L.R. Fischer, and J.C. Kluznik Does diabetes double the risk of depression? Ann Fam Med 7 2009 328 335
60. S.O. Ögren, H. Razani, E. Elvander-Tottie, and J. Kehr The neuropeptide galanin as an in vivo modulator of brain 5-HT1A receptors: possible relevance for affective disorders Physiol Behav 92 2007 172 179 (Pubitemid 47374240)
61. S.E. Ozanne, G.S. Olsen, L.L. Hansen, K.J. Tingey, B.T. Nave, and C.L. Wang et al. Early growth restriction leads to down regulation of protein kinase C zeta and insulin resistance in skeletal muscle J Endocrinol 177 2003 235 241 (Pubitemid 36656396)
62. M.S. Petrisic, S.J. Augood, and R.J. Bicknell Monoamine transporter gene expression in the central nervous system in diabetes mellitus J Neurochem 68 1997 2435 2441 (Pubitemid 27218164)
63. V.L. Pinto, T.M. Brunini, M.R. Ferraz, A. Okinga, and A.C. Mendes-Ribeiro Depression and cardiovascular disease: role of nitric oxide Cardiovasc Hematol Agents Med Chem 6 2008 142 149 (Pubitemid 351935021)
64. V.L. Pinto, P.F. de Souza, T.M. Brunini, M.B. Oliveira, M.B. Moss, and M.A. Siqueira et al. Low plasma levels of l-arginine, impaired intraplatelet nitric oxide and platelet hyperaggregability: implications for cardiovascular disease in depressive patients J Affect Disord 140 2012 187 192
65. N.J. Poritsanos, T.M. Mizuno, M.E. Lautatzis, and M. Vrontakis Chronic increase of circulating galanin levels induces obesity and marked alterations in lipid metabolism similar to metabolic syndrome Int J Obes (Lond) 33 2009 1381 1389
66. L. Qi, F.B. Hu, and G. Hu Genes, environment, and interactions in prevention of type 2 diabetes: a focus on physical activity and lifestyle changes Curr Mol Med 8 2008 519 532
67. R.E. Roberts, S. Deleger, W.J. Strawbridge, and G.A. Kaplan Prospective association between obesity and depression: evidence from the Alameda County Study Int J Obes Relat Metab Disord 27 2003 514 521 (Pubitemid 36520852)
68. C. Roos, J. Lidfeldt, C.D. Agardh, P. Nyberg, C. Nerbrand, and G. Samsioe et al. Insulin resistance and self-rated symptoms of depression in Swedish women with risk factors for diabetes: the Women's Health in the Lund Area study Metabolism 56 2007 825 829 (Pubitemid 46734090)
69. F. Rotella, and E. Mannucci Diabetes mellitus as a risk factor for depression. A meta-analysis of longitudinal studies Diabetes Res Clin Pract 99 2013 98 104
70. M.L. Rovin, K.A. Boss-Williams, R.S. Alisch, J.C. Ritchie, D. Weinshenker, and C.H. West et al. Influence of chronic administration of antidepressant drugs on mRNA for galanin, galanin receptors, and tyrosine hydroxylase in catecholaminergic and serotonergic cell-body regions in rat brain Neuropeptides 46 2012 81 91
71. R.R. Rubin, and M. Peyrot Was Willis right? Thoughts on the interaction of depression and diabetes Diabetes Metab Res Rev 18 2002 173 175 (Pubitemid 34778379)
72. I. Saar, J. Lahe, K. Langel, J. Runesson, K. Webling, and J. Järv et al. Novel systemically active galanin receptor 2 ligands in depression-like behavior J Neurochem 127 2013 114 123
73. I. Saar, J. Runesson, J. Järv, K. Kurrikoff, and U. Langel Novel galanin receptor subtype specific ligand in depression like behavior Neurochem Res 38 2013 398 404
74. N.R. Sciolino, R.K. Dishman, and P.V. Holmes Voluntary exercise offers anxiolytic potential and amplifies galanin gene expression in the locus coeruleus of the rat Behav Brain Res 233 2012 191 200
75. C.J. Swanson, T.P. Blackburn, X. Zhang, K. Zheng, Z.Q. Xu, and T. Hökfelt Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299 Proc Natl Acad Sci U S A 102 2005 17489 17494 (Pubitemid 41740893)
76. G. Tang, Y. Wang, S. Park, N.S. Bajpayee, D. Vi, and Y. Nagaoka Go2 G protein mediates galanin inhibitory effects on insulin release from pancreatic β cells Proc Natl Acad Sci U S A 109 2012 2636 2641
77. K. Tatemoto, A. Rökaeus, H. Jörnvall, T.J. McDonald, and V. Mutt Galanin - a novel biologically active peptide from porcine intestine FEBS Lett 164 1983 124 128 (Pubitemid 14201839)
78. R. Taylor Insulin resistance and type 2 diabetes Diabetes 61 2012 778 779
79. F.S. Thong, P.J. Bilan, and A. Klip The Rab GTPase-activating protein AS160 integrates Akt, protein kinase C, and AMP-activated protein kinase signals regulating GLUT4 traffic Diabetes 56 2007 414 423
80. K. Tsuda, S. Tsuda, I. Nishio, Y. Masuyama, and M. Goldstein Effects of galanin on dopamine release in the central nervous system of normotensive and spontaneously hypertensive rats Am J Hypertens 11 1998 1475 1479 (Pubitemid 29030313)
81. P.G. Unschuld, M. Ising, A. Erhardt, S. Lucae, M. Kohli, and S. Kloiber et al. Polymorphisms in the galanin gene are associated with symptom-severity in female patients suffering from panic disorder J Affect Disord 105 2008 177 184 (Pubitemid 350236362)
82. P.G. Unschuld, M. Ising, D. Roeske, A. Erhardt, M. Specht, and S. Kloiber et al. Gender-specific association of galanin polymorphisms with HPA-axis dysregulation, symptom severity, and antidepressant treatment response Neuropsychopharmacology 35 2010 1583 1592
83. S. Wang, T. Hashemi, S. Fried, A.L. Clemmons, and B.E. Hawes Differential intracellular signaling of the GalR1 and GalR2 galanin receptor subtypes Biochemistry 37 1998 6711 6717 (Pubitemid 28228104)
84. Y.J. Wang, H. Li, Y.T. Yang, C.L. Tie, F. Li, and Z.Q. Xu et al. Association of galanin and major depressive disorder in the Chinese Han population PLoS One 8 2013 e64617
85. K.E. Webling, J. Runesson, T. Bartfai, and U. Langel Galanin receptors and ligands Front Endocrinol (Lausanne) 3 2012 146
86. J.M. Weiss, R.W. Bonsall, M.K. Demetrikopoulos, M.S. Emery, and C.H. West Galanin: a significant role in depression? Ann N Y Acad Sci 863 1998 364 382 (Pubitemid 29047787)
87. J.M. Weiss, K.A. Boss-Williams, J.P. Moore, M.K. Demetrikopoulos, J.C. Ritchie, and C.H. West Testing the hypothesis that locus coeruleus hyperactivity produces depression-related changes via galanin Neuropeptides 39 2005 281 287 (Pubitemid 40804598)
88. D.R. Whiting, L. Guariguata, C. Weil, and J. Shaw IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030 Diabetes Res Clin Pract 94 2011 311 321
89. M. Yamada, Y. Makino, T. Hashimoto, A. Sugiyama, J. Oka, and M. Inagaki et al. Induction of galanin after chronic sertraline treatment in mouse ventral dentate gyrus Brain Res 1516 2013 76 82
90. M. Yu, P. Fang, M. Shi, Y. Zhu, Y. Sun, and Q. Li et al. Galanin receptors possibly modulate the obesity-induced change in pain threshold Peptides 44 2013 55 59
91. R. Yun, J.T. Dourmashkin, J. Hill, E.C. Gayles, S.K. Fried, and S.F. Leibowitz PVN galanin increases fat storage and promotes obesity by causing muscle to utilize carbohydrate more than fat Peptides 26 2005 2265 2273 (Pubitemid 41584094)
92. Z. Zhang, S. Sheng, L. Guo, G. Li, L. Zhang, and L. Zhang et al. Intracerebroventricular administration of galanin antagonist sustains insulin resistance in adipocytes of type 2 diabetic trained rats Mol Cell Endocrinol 361 2012 213 218
93. Z. Zhang, C. Gu, P. Fang, M. Shi, Y. Wang, and Y. Peng et al. Endogenous galanin as a novel biomarker to predict gestational diabetes mellitus Peptides 54 2014 186 189
94. X. Zhao, R.R. Seese, K. Yun, T. Peng, and Z. Wang The role of galanin system in modulating depression, anxiety, and addiction-like behaviors after chronic restraint stress Neuroscience 246 2013 82 93
95. E.P. Zorrilla, M. Brennan, V. Sabino, X. Lu, and T. Bartfai Galanin type 1 receptor knockout mice show altered responses to high-fat diet and glucose challenge Physiol Behav 91 2007 479 485 (Pubitemid 47247780)